Beta Drugs Ltd. benchmarking: Performance to industry peers

Financial

	Beta Drugs	Venus Remedies	Indoco Remedies
Operational Metrics
Financials
5 yr Average ROE	22.74 %	8.87 %	10.38 %
5yr average Equity Multiplier	1.82	1.32	1.9
5yr Average Asset Turnover Ratio	1.03	0.96	0.88
5yr Avg Net Profit Margin	12.23 %	6.91 %	5.41 %
Price to Book	9.47	3.45	2.4
P/E	55.87	22.28	0.0
5yr Avg Cash Conversion Cycle	7.75 Days	46.96 Days	35.3 Days
Inventory Days	46.07 Days	75.64 Days	70.6 Days
Days Receivable	91.57 Days	54.28 Days	83.16 Days
Days Payable	119.03 Days	58.86 Days	111.01 Days
5yr Average Interest Coverage Ratio	14.42	396.11	7.53
5yr Avg ROCE	27.84 %	8.42 %	13.6 %
5yr Avg Operating Profit Margin	21.76 %	10.14 %	14.97 %
5 yr average Debt to Equity	0.29	0.08	0.49
5yr CAGR Net Profit	29.34 %	-6.01 %	n/a
5yr Average Return on Assets	12.69 %	6.69 %	5.31 %
Shareholdings
Promoter Holding	64.63 %	41.76 %	58.86 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-2.1 %	0.0	0.17 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.36 %

	Beta Drugs	Venus Remedies	Indoco Remedies
Product Wise Break-Up	Product Wise Break-Up Oncology 100.0 Pharmaceuticals 0 CRO, Analytical Services 0 API 0 Formulation 0	Product Wise Break-Up Formulation 0 API 0 CRO, Analytical Services 0 Oncology 0 Pharmaceuticals 100.0	Product Wise Break-Up Formulations 90.0 Active Pharmaceutical Ingredient (API) 9.0 CRO, Analytical Services 1.0 Oncology 0 Pharmaceuticals 0
Location Wise Break-Up	Location Wise Break-Up India 71.03 India 0 Rest of the World 0 Others 28.97	Location Wise Break-Up Rest of the World 0 India 33.0 Others 67.0	Location Wise Break-Up Rest of the World 45.79 India 54.21